TEHACHAPI VALLEY HEALTHCARE DISTRICT POLICY MEDSUN MEDICAL DEVICE

TEHACHAPI VALLEY HEALTHCARE DISTRICT POLICY MEDSUN MEDICAL DEVICE






TEHACHAPI VALLEY HEALTHCARE DISTRICT POLICY MEDSUN  MEDICAL DEVICE Tehachapi Valley Healthcare District



POLICY: MedSun / Medical Device Reporting

Policy




POLICY NUMBER: 100.100


Original/Rewrite Approved: 12/28/2010

Originating Dept: Administration


Applies to Depts: Clinical Departments


TEHACHAPI VALLEY HEALTHCARE DISTRICT POLICY MEDSUN  MEDICAL DEVICE


POLICY

It shall be the policy of the Tehachapi Valley Healthcare District (TVHD) that all incidents involving patient care devices, related equipment hazards, and explant devices suspected of a possible failure be appropriately reported to the Safety Committee and MedSun (Medical product safety Network). This policy is required in order to conform to the Safe Medical Device Act of 1990 and FDA regulations.


PROCEDURE

This procedure applies to any personnel who discover, witness, or are notified of a suspected medical device malfunction, or problems such as close calls, or concerns regarding the safety of a device. Included within the scope of this policy are personnel who use or operate a medical device, including physicians, nurses, technicians, therapists, or other medical personnel.


A. Individual Reporting of Devices (Other than Impant/Explant Devices): Any individual who witnesses, discovers, or otherwise becomes aware of information that reasonably suggests that a medical device (equipment and/or product) has caused (or may cause) or contributed to the death, serious injury, or serious illness of a patient or employee of the facility, is responsible for immediately completing a Quality Review Report (see #)


In addition the following steps must be taken:








incident, record the patient's physical findings, and document in the patient's progress notes the occurrence of the suspected adverse medical device incident and any actions taken based on the examination.


Implant/explant devices that are removed solely because of end of life and/or end of use are sent to Purchasing Department along with an explant form. The Purchasing Department will contact BioMedical and determine whether the device is trackable, send necessary notifications to the manufacturers, send the device to the manufacturer, return nontrackable devices to departments if requested, and/or dispose of the device.


The following information should be documented, if applicable:




This responsibility will include the following:

  1. Reviewing and analyzing all reportable incidents involving medical devices.

  2. Reviewing and overseeing all reportable devices suspected of failure and/or

defect that might cause harm.


oversee compliance for the Quantros Reporting and Adverse Event/

Sentinel Event policies. The Risk Management staff will be responsible for

the following activities:

  1. Coordinate risk identification and investigation activities with appropriate

departments.

  1. Ensure that all data collected from the medical device reporting program shall

be incorporated into the Quantros reporting system.

  1. Review the recommendation of the Hospital Departmental Performance Improvement Committee for corrective actions

Involving any possible liability to the facility.



DEFINITIONS


MedSun: MedSun is an FDA internet-based system designed to provide a secure way to report adverse medical device events. MedSun also captures additional reporting on close calls or rejection of a device over safety concerns.


Safe Medical Device Act of 1990: The Safe Medical Device Act of 1990 was passed by the United States Congress to better protect the public health by increasing reports of device related adverse events by both manufacturers and user facilities.


Medical Device: In the Medical Device Act, the FDA defines a medical device as any

instrument, apparatus, or other article that is used to prevent, diagnose, mitigate, or treat a disease or to affect the structure or function of the body, with the exception of drugs. For example, a medical device includes but is not limited to ventilators, monitors, dialyzers, and any other electronic equipment, implants, thermometers, patient restraints, syringes, catheters, in vitro diagnostic test kits and reagents, disposables, components, parts, accessories, and related software. FDA Investigational Devices are not included in this policy. The principal investigator or their designee under stringent FDA guidelines handles these devices.

Implant/Explant Device: An implant/explant device is a device that is placed/removed

into/out of a surgically or naturally formed cavity in the human body. The purpose of this

device is to continually assist, restore, or replace the function of an organ system or

structure of the human body throughout the useful life of the device. These devices are

totally encased by the human body. Any external component must not form a physical

connection to the device.


Device Failure: A device failure is the failure of a device to perform or function as

intended, including any deviations from the device's performance specifications or

intended use.


FDA Reportable Event: A reportable event is an event where a device has the potential to cause or contributed to a serious injury, serious illness, or death of a patient or employee. This event may include equipment malfunctions and/or user errors. Reporting to the FDA is required within ten working days.


Reference:

Safe Medical Device Act of 1990 and 60 Fed Reg 63579 (1995)


Additional Policies:

Quantros, 100.28

Tagging Defective Equipment, 110.39

4







Tags: device reporting, medical device, district, healthcare, policy, valley, tehachapi, device, medical, medsun